Gross profit for various pharmaceutical distributors before EBITDA from 2016-2017

Published by
Matej Mikulic,
Sep 30, 2019
This statistic shows the share of gross profit converted to earnings before interest, taxes, depreciation and amortization among various levels of U.S. pharmaceutical supply chains in 2016-2017. According to the data, pharmacy benefit managers converted 85 percent of gross profits to EBITDA.

Share of gross profit converted to EBITDA among U.S. drug supply chain levels in 2016-2017*

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

July 2019

Region

United States

Survey time period

2016 and 2017

Supplementary notes

Calculated as EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) margin divided by gross margin

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Spain "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Spain

Overview

6

International trade

6

Pharmaceutical sales

6

Pharmaceutical expenditure of the National Health System

6

Research and development

6

Company rankings

6

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical market in ThailandDemographics of ThailandHealth in ThailandMedical device industry in ThailandCoronavirus (COVID-19) pandemic in Thailand
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.